Mike Smith

Mike Smith is an EVP, Chief Financial Officer, Head of Corporate Development at Zogenix. Mr. Smith has served as Catalyst Biosciences’ Chief Financial & Business Advisor since June 2012. He brings over 15 years experience in the biopharmaceutical industry in executive and management roles in Corporate Development, Strategy, Finance, Commercial and Project Management functions for companies ranging in size from 5,000 to 10 employees.

Mr. Smith was most recently at iPierian as Vice President of Business Development.

Prior to that, he served as CFO and Head of Business Development for Memory Pharmaceuticals (Nasdaq: MEMY), which was acquired by Roche in 2009, where he was responsible for overseeing all business development, finance, strategic planning, intellectual property and eventually site operation activities.

Prior to Memory, Mr. Smith was Vice President of Business Development at QLT, Inc. (Nasdaq: QLTI).

Mr. Smith entered the industry with Chiron (Nasdaq: CHIR) which was acquired by Novartis in 2006. Throughout his career, Mr. Smith has managed and led numerous hundred+ million dollar company acquisitions, product licensing transactions and strategic partnerships and financings.

Mr. Smith holds a B.S. from the University of Virginia, as well as an MBA from the University of California, Berkeley.

Mike Smith is the EVP, Chief Financial Officer, Head of Corporate Development at Zogenix, based in United States, North America. With a background in Biotechnology, Mike Smith has a rich history of leadership and innovation.Mike Smith studied MBA unknown at University of California Berkeley. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.